Markets

Health Care Sector Update for 01/21/2016: DPLO,NVS,TROV,ALKS

Top Health Care Stocks

JNJ +0.63%

PZE +0.39%

MRK +0.24%

ABT +1.29%

AMGN -0.93%

Health care stocks were narrowly higher, with the NYSE Health Care Index climbing about 0.3% while shares of health care companies in the S&P 500 were up about 0.1% as a group.

In company news, Diplomat Pharmacy ( DPLO ) advanced Thursday after saying it is now filling prescriptions for Cosentx following the approval of two new indications for the interleukin antagonist.

The U.S. Food and Drug Administration recently added the treatment of active ankylosing spondylitis and active psoriatic arthritis to the approved indications for Cosentx, which is manufactured for Diplomat Pharma by Novartis ( NVS ).

DPLO shares were up nearly 1% at $31.38 apiece, easing from an earlier rise to $32.09 a share. NVS shares were down almost 1% at $79.93 each, dropping to a session low of $79.27 a share during morning trading.

In other sector news,

(+) TROV, (+30.8%) Signs agreement with America's Choice Provider Network allowing for access to its entire suite of circulating tumor ctDNA Precision Cancer Monitoring tests and services.

(-) ALKS, (-42.1%) Announces topline results from Phase III testing of its ALKS 5461 drug candidate in patients with major depressive disorder, with a greater placebo response and no treatment effect of ALKS 5461 observed.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

DPLO NVS

Other Topics

Commodities